(Q35626591)

9 August 2017

title

Treatment of hyperkalaemia with intravenous salbutamol (English)

1 reference

9 August 2017

0 references

Murdoch IA

1

1 reference

9 August 2017

Dos Anjos R

series ordinal

2

1 reference

9 August 2017

Haycock GB

series ordinal

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 April 1991

1 reference

Archives of Disease in Childhood

9 August 2017

published in

1 reference

9 August 2017

volume

66

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

527-528

1 reference

Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure

9 August 2017

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1793005

Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol

27 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1793005

Inhaled bronchodilators and hypokalaemia

27 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2031614

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment of hyperkalaemia in renal failure: salbutamol v. insulin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2031614

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Impairment of beta 2-adrenoceptor-stimulated potassium uptake in end-stage renal disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2031614

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ADC.66.4.527

1 reference

9 August 2017

1 reference

9 August 2017

1 reference